1. Home
  2. UTHR vs NVR Comparison

UTHR vs NVR Comparison

Compare UTHR & NVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$531.38

Market Cap

23.9B

Sector

Health Care

ML Signal

HOLD

Logo NVR Inc.

NVR

NVR Inc.

HOLD

Current Price

$6,485.59

Market Cap

21.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTHR
NVR
Founded
1996
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
23.9B
21.8B
IPO Year
1999
1995

Fundamental Metrics

Financial Performance
Metric
UTHR
NVR
Price
$531.38
$6,485.59
Analyst Decision
Buy
Buy
Analyst Count
14
4
Target Price
$531.79
$8,112.50
AVG Volume (30 Days)
477.5K
17.4K
Earning Date
04-29-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
13.07
N/A
EPS
27.86
436.55
Revenue
$1,483,300,000.00
$10,323,959,000.00
Revenue This Year
$7.77
N/A
Revenue Next Year
$11.11
$7.02
P/E Ratio
$19.04
$14.82
Revenue Growth
2.38
N/A
52 Week Low
$266.98
$6,368.70
52 Week High
$548.12
$8,618.28

Technical Indicators

Market Signals
Indicator
UTHR
NVR
Relative Strength Index (RSI) 58.35 27.85
Support Level $464.92 N/A
Resistance Level $542.66 $7,751.09
Average True Range (ATR) 14.71 158.99
MACD 2.68 -59.63
Stochastic Oscillator 76.95 8.37

Price Performance

Historical Comparison
UTHR
NVR

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

About NVR NVR Inc.

NVR Inc is a United States-based homebuilding company. It builds single-family detached homes, townhomes, and condominium buildings under three brands, Ryan Homes, NVHomes, and Heartland Homes. The company through its subsidiary also operates a mortgage banking and title services business. The homebuilding segment includes four geographic areas of the Mid-Atlantic, North East, Mid-East, and South East.

Share on Social Networks: